An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.
AAO 2024: Bonnie An Henderson, MD, explores future of medical education in Kelman Lecture
Spotlighting telemedicine in the year of a pandemic
Small hyperreflective retinal foci: An in vivo imaging feature of resident microglia activation in geographic atrophy
Digital Exclusive: An interview with David Eichenbaum, MD, on his ASRS 2024 presentation
Inflammasome Therapeutics completes enrollment of Phase I PK/Safety for K9
Enrollment complete of phase 2b of SIGLEC study to assess safety and efficacy of AVD-104 for GA secondary to AMD